The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

24 Apr 2020 07:00

RNS Number : 7210K
Catenae Innovation PLC
24 April 2020
 

24 April 2020

Catenae Innovation PLC

("Catenae", or the "Company")

 

Directorate Changes

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, is pleased to announce the appointment of Brian Thompson and John Farthing to the Board as Non-Executive Chairman and Chief Financial Officer, respectively, with immediate effect.

 

Kevin Everett, Interim Non-Executive Chairman since 17 July 2019 and Non-Executive Director since 16 May 2013, will step down from his role with immediate effect, to pursue other business interests.

 

Brian Thompson's proposed appointment was announced on 31 January 2020. Mr Thompson is an entrepreneur and is the founder owner of Newcastle-based B.T.I.C. Ltd, a successful business that has operated in the insurance industry since 1985. He is also a director of Third Eye Neurotech Ltd.

 

John Farthing's appointment as Chief Financial Officer of the Company was announced on 24 January 2019 and his proposed appointment to the Board was announced on 23 December 2019. John qualified as a Chartered Accountant in 1988. Following a career in stockbroking, John has experience working with both UK listed as well as private companies. John is also a Chartered Fellow of the Chartered Institute for Securities & Investment and a Liveryman of the Worshipful Company of World Traders.

 

Further disclosure on Brian Thompson and John Farthing pursuant to Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies is set out below.

 

In order to conserve the Company's working capital, the directors have agreed to take part of their remuneration in shares.

 

Guy Meyer, Interim Chief Executive Officer, commented: "I am delighted to welcome both Brian and John to the Catenae Board at this important time in our development. Their wealth of experience, expertise and business network will add considerable value as we take advantage of potential growth opportunities that are presenting themselves."

 

"I would also like to thank Kevin for his contribution to the Company and I wish him all the very best for the future."

 

"We look forward to updating the market on future progress in due course."

 

 

 

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Brian William Thompson (aged 64) and John Farthing (aged 57):

 

In the 5 years preceding the date of this announcement, Brian Thompson held the following directorships and no partnerships:

 

Current directorships

Past directorships

B.T.I.C. Limited

B.T.I.C (Morpeth) Limited

Little Tinker Limited

Third Eye Technologies Limited

Listenear Limited

Lyncroft Finance Limited

Orbi-Tel Limited

Third Eye Neurotech Limited

 

Mr Thompson holds 31,318,797 ordinary shares in the Company, representing 29.2% of the Company's issued share capital and no options over ordinary shares in the Company.

 

In the 5 years preceding the date of this announcement, John Farthing held the following directorships and partnerships:

 

Current directorships / partnerships

Past directorships / partnerships

Cloisters Capital LLP

Beaufort Securities Limited*

Trust in Media Limited

Charchem Limited

Granville West Limited

Harper, Deane and Farthing Limited

Intoware Limited

Kingston Smith Pension Trustees LLP

Kiru Brand Limited

Niku Restaurant Company Limited

Niku Trading Limited**

Signitoff Limited

SXN21 Limited

 

*Beaufort Securities Limited, a company of which Mr Farthing was a director of until 2 March 2018, entered administration on 1 March 2018 and ended administration on 3 March 2020. There was only one insolvency case.

 

**Niku Trading Limited, a company of which Mr Farthing was a director of until 7 October 2016, entered liquidation within one month of Mr Farthing's tenure as director via a voluntary creditors liquidation. A liquidator was appointed on 18 October 2016 and the company was dissolved on 17 September 2019. There was only one insolvency case.

 

Crowd Source Solutions Limited, a company of which Mr Farthing was a director of, was dissolved via a members voluntary liquidation. A liquidator was appointed on 19 August 2013 and the company was dissolved on 28 October 2014 via a solvent liquidation.

 

Mr Farthing holds 1,341,702 ordinary shares in the Company, representing 1.25% of the Company's issued share capital and no options over ordinary shares in the Company.

 

 

There is no further information to be disclosed in relation to the appointments of Brian Thompson and John Farthing pursuant to AIM Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Guy Meyer, Interim Chief Executive Officer of the Company.

 

 

- Ends -

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0) 191 580 8545

Guy Meyer, Interim Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44 (0)20 7213 0880

Liam Murray

Jo Turner

Brandon Hill Capital Limited Broker

Andy Gutmann

+44 (0) 20 3463 5000

+44 (0)78796 8313

 

Yellow Jersey PR (PR & IR)

+44 (0)20 3004 9512

Sarah Hollins

Annabel Atkins

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPPUCWCUPUGRW
Date   Source Headline
30th Mar 20213:42 pmRNSDirector dealings
30th Mar 20217:00 amRNSUK Government 'COVID-Status Certification Review'
29th Mar 20217:00 amRNSAnnual Report and Accounts, Trading Update
16th Mar 20211:19 pmRNSExercise of Warrant
16th Mar 20219:05 amRNSSecond Price Monitoring Extn
16th Mar 20219:00 amRNSPrice Monitoring Extension
4th Mar 20217:00 amRNSHolding(s) in Company
3rd Mar 20214:13 pmRNSHolding(s) in Company
26th Feb 202111:00 amRNSCorrection re Placing, Conversions, Warrants
22nd Feb 20214:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20217:00 amRNSDigital Identity Policy Consultation
29th Jan 20217:00 amRNSPilot Agreement
27th Jan 20217:00 amRNSPlacing, Conversions, Warrants & Business Update
11th Jan 20212:06 pmRNSSecond Price Monitoring Extn
11th Jan 20212:01 pmRNSPrice Monitoring Extension
18th Dec 202011:39 amRNSHolding(s) in Company
15th Dec 20203:41 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSBusiness Update
9th Dec 20209:27 amRNSHolding(s) in Company
5th Nov 202012:30 pmRNSUpdate on Afrik-ID
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
2nd Nov 202011:06 amRNSSecond Price Monitoring Extn
2nd Nov 202011:00 amRNSPrice Monitoring Extension
16th Oct 20208:43 amRNSIssue of Warrants
16th Oct 20207:00 amRNSJoint Venture with Blackhive Africa Medical
25th Sep 202012:26 pmRNSResult of AGM
4th Sep 202012:50 pmRNSPosting of Notice of AGM
27th Aug 20204:41 pmRNSSecond Price Monitoring Extn
27th Aug 20204:35 pmRNSPrice Monitoring Extension
25th Aug 20207:00 amRNSBusiness Update
24th Aug 20207:00 amRNSCreditor Share Conversion and Notice of AGM
19th Aug 20202:32 pmRNSHolding(s) in Company
23rd Jul 202011:05 amRNSSecond Price Monitoring Extn
23rd Jul 202011:00 amRNSPrice Monitoring Extension
20th Jul 20207:00 amRNSChange of Director Role and Grant of Options
17th Jul 20207:00 amRNSTransfer and Exercise of Warrants
9th Jul 202011:05 amRNSSecond Price Monitoring Extn
9th Jul 202011:00 amRNSPrice Monitoring Extension
8th Jul 20209:14 amRNSHolding(s) in Company
6th Jul 20202:06 pmRNSSecond Price Monitoring Extn
6th Jul 20202:00 pmRNSPrice Monitoring Extension
6th Jul 20201:15 pmRNSExercise of Warrants
6th Jul 20207:00 amRNSHolding(s) in Company
3rd Jul 20207:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSCompletion of New Product - Onsite ID
3rd Jul 20207:00 amRNSCommercial Pilot Agreement with Afrik-ID
2nd Jul 20208:01 amRNSHolding(s) in Company
1st Jul 20203:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.